Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2019-05-21 Director's Dealing
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2019-05-21 English
Board/Management Information 2019
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated May 17, 2019, by Medpace Holdings, Inc. The key content is the appointment of Ashley M. Keating to the Board of Directors, including details about her background, role, and compensation. This is a clear announcement of a change in the company's board of directors. There are no financial statements or earnings data, so it is not an earnings release or financial report. The document fits the category of Board/Management Information (MANG) as it announces a director appointment and related management changes.
2019-05-21 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated May 17, 2019, reporting the submission of matters to a vote of security holders at the 2019 Annual Meeting of Stockholders. It includes detailed voting results for director election and ratification of the independent auditor. The content is focused on official voting results from a shareholder meeting, not the meeting materials or the full annual report. The document length is 3790 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, this filing corresponds to Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-05-17 English
FORM 4
Director's Dealing
2019-05-08 English
FORM 4
Director's Dealing
2019-05-06 English
10-Q
Interim / Quarterly Report Q1 2019
2019-04-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.